# Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC

> **NCT03032913** · — · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 52 (actual)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma (PDAC)

## Interventions

- **PROCEDURE:** Blood samples
- **PROCEDURE:** Portal vein blood sample

## Key facts

- **NCT ID:** NCT03032913
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-15
- **Primary completion:** 2017-11-13
- **Final completion:** 2017-11-13
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2018-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03032913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03032913, "Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03032913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*